Toll-Free 1-866-625-9854

Synalar Oftalmico (Fluocinolone Acetonide)

Active Ingredient: Fluocinolone Acetonide
Dosage: 15 ml
Route of Administration: Ocular
Dosage Form: Solution
Quantity per package: 1 unit
Availability: Out of stock

Why is Synalar Oftalmico not used in the USA?

In the USA, Synalar Oftalmico is not used due to FDA regulations and the availability of alternative treatments that are preferred under U.S. healthcare standards. The American market has strict guidelines for ophthalmic medications, and other drugs might have gained approval for their effectiveness or safety profiles over Synalar Oftalmico. As this drug is out of stock now, we’ve collected a list of eye drops available at the moment.

Eye Drops for Various Conditions Available in the USA

See also  Prednefrin SF (Prednisolone)

What is Synalar Oftalmico?

Synalar Oftalmico is a steroid medicine that is used to treat eye inflammation that is caused by disease or infection. It reduces swelling, redness, itching, and allergic reactions within the eye. The medication reduces symptoms such as swelling, redness, and itching by suppressing immune responses in the eye.


Synalar Oftalmico is indicated in:

  • atopic conjunctivitis;
  • selective infectious conjunctivitis;
  • allergic and pruritic conjunctivitis;
  • iritis;
  • cyclitis;
  • superficial punctate keratitis;
  • corneal injury by chemical agents;
  • thermal burns;
  • penetration and removal of foreign bodies.

These eye drops are prescribed for the treatment of inflammatory, allergic conditions and infections of the anterior eye segment.

Popularity and Use in Specific Countries

Synalar Oftalmico is particularly popular in certain countries within Latin America and Southeast Asia. These regions often face climatic and environmental conditions that contribute to a higher incidence of infectious and inflammatory eye diseases. For example, countries like Mexico, Brazil, and the Philippines have reported wider use of such ophthalmic corticosteroids. The reasons for the popularity of Synalar Oftalmico in these regions include:

  • High humidity and heat, which can foster the growth of microorganisms that lead to eye infections.
  • Dense populations in urban areas, which may lead to increased spread of contagious eye diseases.
  • Varying levels of access to healthcare, which can affect the prevention and treatment strategies for eye conditions.

In these countries, Synalar Oftalmico is used due to its effectiveness in quickly reducing symptoms of eye inflammation, providing relief from discomfort and preventing further complications associated with eye infections or inflammatory conditions.

Dosage and administration

Ocular solution: 2 or 3 drops inside the conjunctival sac every 3 or 4 hours. More frequently (every 1 or 2 hours), depending on the acute nature of the infection. There is no evidence that exceeding the recommended dose is more effective, therefore, larger doses should cause severe side effects.

See also  Hyalox Ofteno (Oximetazoline)


Acute herpes simplex;

  • Ulcerations of the eye caused by herpes simplex or herpes zoster;
  • Fungal diseases of eye structures.
  • Vaccination, chickenpox and most viral diseases of the cornea and conjunctiva;
  • Ocular tuberculosis;
  • Hypersensitivity to any of the drug components.

Side effects

  • Punctures;
  • Burning;
  • Irritation;
  • Secondary infection;
  • Glaucoma.


The use of Synalar Oftalmico in humans has not been related to the effects of carcinogenesis, mutagenesis, teratogenesis. Besides, it has not been related to impaired fertility.


No data detected.


No data detected.